XML 15 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 26, 2021
Jun. 27, 2020
Jun. 26, 2021
Jun. 27, 2020
Revenues:        
Total revenues $ 9,905,256 $ 8,814,646 $ 21,581,624 $ 16,693,251
Expenses:        
Cost of product revenues 6,044,543 4,779,577 12,441,213 10,427,424
Research and development 3,740,253 2,221,154 7,303,553 4,560,902
Selling, general and administration 4,040,979 2,909,366 9,946,685 6,341,457
Total expenses 13,825,775 9,910,097 29,691,451 21,329,783
Loss from operations (3,920,519) (1,095,451) (8,109,827) (4,636,532)
Other income (expense):        
Interest income 3,541 34,030 12,285 107,436
Other expense, net (896) (49,757) (2,045) (37,080)
Foreign currency transaction gains (losses) 100,991 9,995 129,981 (162,998)
Total other income and expense 103,636 (5,732) 140,221 (92,642)
Loss before provision for income taxes and net loss attributable to noncontrolling interest (3,816,883) (1,101,183) (7,969,606) (4,729,174)
Tax provision (32,000) (42,000) (65,000) (71,000)
Net loss (3,848,883) (1,143,183) (8,034,606) (4,800,174)
Net loss attributable to the noncontrolling interest 16 21,642 39,501 83,114
Net loss attributable to Kopin Corporation $ (3,848,867) $ (1,121,541) $ (7,995,105) $ (4,717,060)
Net loss per share        
Basic and diluted $ (0.04) $ (0.01) $ (0.09) $ (0.06)
Weighted average number of common shares outstanding        
Basic and diluted 88,815,356 82,569,379 88,096,822 82,552,896
Net Product Revenues [Member]        
Revenues:        
Total revenues $ 6,928,819 $ 6,670,303 $ 14,497,663 $ 12,589,509
Research And Development Revenues [Member]        
Revenues:        
Total revenues $ 2,976,437 $ 2,144,343 $ 7,083,961 $ 4,103,742